{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:16:09Z","timestamp":1760015769491},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Scientific Research Projects Coordination Unit of Istanbul University","award":["946"],"award-info":[{"award-number":["946"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.gene.2013.03.136","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T02:02:12Z","timestamp":1366164132000},"page":"20-26","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes"],"prefix":"10.1016","volume":"523","author":[{"given":"Hulya","family":"Yilmaz-Aydogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Kurnaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Kucukhuseyin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basak","family":"Akadam-Teker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison Pinar","family":"Eronat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atike","family":"Tekeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehra","family":"Bugra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguz","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2013.03.136_bb0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.med.57.121304.131428","article-title":"Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia","volume":"57","author":"Beaven","year":"2006","journal-title":"Annu. Rev. Med."},{"issue":"11","key":"10.1016\/j.gene.2013.03.136_bb0010","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gene.2013.03.136_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","article-title":"Apolipoprotein E polymorphism and atherosclerosis","volume":"8","author":"Davignon","year":"1988","journal-title":"Arteriosclerosis"},{"issue":"3","key":"10.1016\/j.gene.2013.03.136_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.metabol.2008.09.026","volume":"58","author":"Do","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.gene.2013.03.136_bb0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s001250051357","article-title":"Variation in the PPARa gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects","volume":"43","author":"Flavell","year":"2000","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.gene.2013.03.136_bb0040","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.0000012145.80593.25","article-title":"Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease","volume":"105","author":"Flavell","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.gene.2013.03.136_bb0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00008571-200412000-00005","article-title":"Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G\/C intron7 polymorphism in subjects with type 2 diabetes","volume":"14","author":"Foucher","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"12","key":"10.1016\/j.gene.2013.03.136_bb0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10038-004-0208-6","article-title":"Population prevalence of APOE, APOC3 and PPAR-a mutations associated to hypertriglyceridemia in French Canadians","volume":"49","author":"Garenc","year":"2004","journal-title":"J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.gene.2013.03.136_bb0030","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ahj.2003.12.005","article-title":"Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls","volume":"147","author":"Gouni-Berthold","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.gene.2013.03.136_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9150(02)00002-3","article-title":"Genetic determinants of the response to benzafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial","volume":"163","author":"Jamshidi","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2013.03.136_bb0055","first-page":"1146","article-title":"Recommendation for human blood pressure determination of by sphygmomanometers","volume":"62","author":"Kirkendall","year":"1980","journal-title":"Circulation"},{"issue":"30","key":"10.1016\/j.gene.2013.03.136_bb0060","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.2174\/092986710792927822","article-title":"Triglyceride level affecting shared susceptibility genes in metabolic syndrome and coronary artery disease","volume":"17","author":"Kisfali","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.gene.2013.03.136_bb0065","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/clinchem\/36.12.2087","article-title":"Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing","volume":"36","author":"Kontula","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/j.gene.2013.03.136_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2004.07.012","article-title":"An overview on biological mechanisms of PPARs","volume":"51","author":"Kota","year":"2005","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.gene.2013.03.136_bb0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0021-9150(00)00570-0","article-title":"Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study","volume":"154","author":"Lahoz","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2013.03.136_bb0080","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.RES.83.11.1097","article-title":"Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells","volume":"83","author":"Marx","year":"1998","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.gene.2013.03.136_bb0085","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.CIR.89.3.1333","article-title":"Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)","volume":"89","author":"National Cholesterol Education Program","year":"1994","journal-title":"Circulation"},{"issue":"2\u20133","key":"10.1016\/j.gene.2013.03.136_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-5273(03)00101-3","article-title":"Gene\u2013gene interaction of PPAR\u03b3 and ApoE affects coronary heart disease risk","volume":"92","author":"Peng","year":"2003","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.gene.2013.03.136_bb0090","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1017\/S000711450938215X","article-title":"Plasma n\u22123 fatty acid response to an n\u22123 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men","volume":"102","author":"Plourde","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.gene.2013.03.136_bb0100","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1073\/pnas.95.13.7614","article-title":"Expression of the peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein","volume":"95","author":"Ricote","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.gene.2013.03.136_bb0105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10038-004-0177-9","article-title":"Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome","volume":"49","author":"Robitaille","year":"2004","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.gene.2013.03.136_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0028-1082069","article-title":"The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition","volume":"117","author":"Silbernagel","year":"2009","journal-title":"Exp. Clin. Endocrinol. Diab."},{"issue":"5","key":"10.1016\/j.gene.2013.03.136_bb0115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.ATV.0000012302.11991.42","article-title":"Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study","volume":"22","author":"Tai","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.gene.2013.03.136_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2005.08.034","article-title":"The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT)","volume":"187","author":"Tai","year":"2006","journal-title":"Atherosclerosis"},{"issue":"Suppl. 1","key":"10.1016\/j.gene.2013.03.136_bb0125","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.21.1.S5","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (Committee Report)","volume":"21","author":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.gene.2013.03.136_bb0130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-2275(20)32037-X","article-title":"Molecular scanning of the human PPAR a gene: association of the L162V mutation with hyperapobetalipoproteinemia","volume":"41","author":"Vohl","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2013.03.136_bb0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2840-9-13","article-title":"PPARg gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus","volume":"9","author":"Wan","year":"2010","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.gene.2013.03.136_bb0140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0008-6363(99)00256-4","article-title":"Peroxisome proliferator-activated receptor gamma C161\u2192T polymorphism and coronary artery disease","volume":"44","author":"Wang","year":"1999","journal-title":"Cardiovasc. Res."},{"issue":"1\u20132","key":"10.1016\/j.gene.2013.03.136_bb0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11010-011-0987-y","article-title":"Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without type 2 diabetes","volume":"358","author":"Yilmaz-Aydogan","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.gene.2013.03.136_bb0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/dna.2011.1464","article-title":"Investigation of polymorphic variants of PPARD and APOE genes in Turkish coronary heart disease patients","volume":"31","author":"Yilmaz-Aydogan","year":"2012","journal-title":"DNA Cell Biol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913004332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913004332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:30:52Z","timestamp":1644798652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111913004332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0378111913004332"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2013.03.136","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2013.03.136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}